Aldeyra Stock Performance
| ALDX Stock | USD 3.91 0.02 0.51% |
On a scale of 0 to 100, Aldeyra holds a performance score of 8. The firm shows a Beta (market volatility) of 2.79, which signifies a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Aldeyra will likely underperform. Please check Aldeyra's maximum drawdown, and the relationship between the information ratio and expected short fall , to make a quick decision on whether Aldeyra's price patterns will revert.
Risk-Adjusted Performance
8 of 100
Weak | Strong |
OK
Compared to the overall equity markets, risk-adjusted returns on investments in Aldeyra are ranked lower than 8 (%) of all global equities and portfolios over the last 90 days. In spite of fairly uncertain fundamental indicators, Aldeyra showed solid returns over the last few months and may actually be approaching a breakup point. ...more
Actual Historical Performance (%)
One Day Return 1.02 | Year To Date Return 12.15 | Ten Year Return (44.86) | All Time Return (44.86) |
1 | Deutsche Bank AG Has 1.97 Million Position in Aldeyra Therapeutics, Inc - AmericanBankingNEWS | 02/26/2024 |
2 | Acquisition by Todd Brady of 1081201 shares of Aldeyra at 3.62 subject to Rule 16b-3 | 03/08/2024 |
3 | Disposition of 97914 shares by Todd Brady of Aldeyra at 3.2735 subject to Rule 16b-3 | 03/11/2024 |
4 | Disposition of 85324 shares by Todd Brady of Aldeyra at 3.05 subject to Rule 16b-3 | 03/12/2024 |
5 | Aldeyra Therapeutics Options Chain Prices 2024 - MarketBeat | 03/18/2024 |
6 | Aldeyra maintains buy rating, stock target amid FDA feedback | 03/28/2024 |
7 | Acquisition by Perceptive Advisors Llc of 186051 shares of Aldeyra at 3.44 subject to Rule 16b-3 | 04/02/2024 |
8 | Aldeyra stock gains as Oppenheimer upgrades | 04/03/2024 |
9 | Acquisition by Perceptive Advisors Llc of 140281 shares of Aldeyra at 4.67 subject to Rule 16b-3 | 04/04/2024 |
10 | Disposition of 13201 shares by Greenberg Bruce of Aldeyra at 3.4064 subject to Rule 16b-3 | 04/17/2024 |
11 | Aldeyra Therapeutics to Host Research Development Day on April 25, 2024 | 04/18/2024 |
12 | Is Aldeyra Therapeutics Outperforming Other Medical Stocks This Year | 04/22/2024 |
| Begin Period Cash Flow | 144.4 M |
Aldeyra |
Aldeyra Relative Risk vs. Return Landscape
If you would invest 300.00 in Aldeyra on January 24, 2024 and sell it today you would earn a total of 93.00 from holding Aldeyra or generate 31.0% return on investment over 90 days. Aldeyra is currently generating 0.5627% in daily expected returns and assumes 5.2956% risk (volatility on return distribution) over the 90 days horizon. In different words, 46% of stocks are less volatile than Aldeyra, and 89% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
Aldeyra Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Aldeyra's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Aldeyra, and traders can use it to determine the average amount a Aldeyra's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.1063
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ALDX | |||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 5.3 actual daily | 46 54% of assets are more volatile |
Expected Return
| 0.56 actual daily | 11 89% of assets have higher returns |
Risk-Adjusted Return
| 0.11 actual daily | 8 92% of assets perform better |
Based on monthly moving average Aldeyra is performing at about 8% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Aldeyra by adding it to a well-diversified portfolio.
Aldeyra Fundamentals Growth
Aldeyra Stock prices reflect investors' perceptions of the future prospects and financial health of Aldeyra, and Aldeyra fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Aldeyra Stock performance.
| Return On Equity | -0.28 | ||||
| Return On Asset | -0.16 | ||||
| Current Valuation | 104.29 M | ||||
| Shares Outstanding | 58.9 M | ||||
| Price To Earning | (4.44) X | ||||
| Price To Book | 2.09 X | ||||
| EBITDA | (42.53 M) | ||||
| Net Income | (37.54 M) | ||||
| Cash And Equivalents | 163.83 M | ||||
| Cash Per Share | 2.80 X | ||||
| Total Debt | 15.66 M | ||||
| Debt To Equity | 0.1 % | ||||
| Current Ratio | 7.83 X | ||||
| Book Value Per Share | 2.02 X | ||||
| Cash Flow From Operations | (30.33 M) | ||||
| Earnings Per Share | (0.64) X | ||||
| Market Capitalization | 231.46 M | ||||
| Total Asset | 148.33 M | ||||
| Retained Earnings | (394.26 M) | ||||
| Working Capital | 125.55 M | ||||
| Current Asset | 28.09 M | ||||
| Current Liabilities | 2.12 M | ||||
About Aldeyra Performance
To evaluate Aldeyra Stock as a possible investment, you need to clearly understand its upside potential, downside risk, and overall future performance outlook. You may be satisfied when Aldeyra generates a 15% return over the last few months, but what if the market is generating 25% over the same period? In this case, it makes sense to compare Aldeyra Stock's performance with different market indexes, such as the Dow or NASDAQ Composite. These indexes can act as benchmarks that will help you to understand Aldeyra market performance in a much more refined way. The Macroaxis performance score is an integer between 0 and 100 that represents Aldeyra's market performance from a risk-adjusted return perspective. Generally speaking, the higher the score, the better is overall performance as compared to other investors. The score is normalized against the average investing universe (the best we can interpret from the data available). Within this methodology, scores of individual equity instruments will always be inferior to the scores of portfolios of equities as portfolios typically diversify a lot of unsystematic risks away. The formula to derive the Macroaxis score bases on multiple unequally-weighted factors. For more information, refer to our portfolio performance evaluation section.
Please also refer to our technical analysis and fundamental analysis pages.| Last Reported | Projected for Next Year | ||
| Days Of Inventory On Hand | -4.1 K | -4.3 K | |
| Return On Tangible Assets | (0.25) | (0.27) | |
| Return On Capital Employed | (0.34) | (0.36) | |
| Return On Assets | (0.25) | (0.27) | |
| Return On Equity | (0.31) | (0.30) |
Things to note about Aldeyra performance evaluation
Checking the ongoing alerts about Aldeyra for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Aldeyra help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Aldeyra is way too risky over 90 days horizon | |
| Aldeyra appears to be risky and price may revert if volatility continues | |
| Net Loss for the year was (37.54 M) with profit before overhead, payroll, taxes, and interest of 0. | |
| Aldeyra currently holds about 163.83 M in cash with (30.33 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 2.8. | |
| Aldeyra has a frail financial position based on the latest SEC disclosures | |
| Roughly 62.0% of the company shares are held by institutions such as insurance companies | |
| Latest headline from zacks.com: Is Aldeyra Therapeutics Outperforming Other Medical Stocks This Year |
- Analyzing Aldeyra's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Aldeyra's stock is overvalued or undervalued compared to its peers.
- Examining Aldeyra's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Aldeyra's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Aldeyra's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Aldeyra's stock. These opinions can provide insight into Aldeyra's potential for growth and whether the stock is currently undervalued or overvalued.
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Aldeyra. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in unemployment. For more information on how to buy Aldeyra Stock please use our How to Invest in Aldeyra guide.Note that the Aldeyra information on this page should be used as a complementary analysis to other Aldeyra's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Correlation Analysis module to reduce portfolio risk simply by holding instruments which are not perfectly correlated.
Complementary Tools for Aldeyra Stock analysis
When running Aldeyra's price analysis, check to measure Aldeyra's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Aldeyra is operating at the current time. Most of Aldeyra's value examination focuses on studying past and present price action to predict the probability of Aldeyra's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Aldeyra's price. Additionally, you may evaluate how the addition of Aldeyra to your portfolios can decrease your overall portfolio volatility.
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity |
Is Aldeyra's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Aldeyra. If investors know Aldeyra will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Aldeyra listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.64) | Return On Assets (0.16) | Return On Equity (0.28) |
The market value of Aldeyra is measured differently than its book value, which is the value of Aldeyra that is recorded on the company's balance sheet. Investors also form their own opinion of Aldeyra's value that differs from its market value or its book value, called intrinsic value, which is Aldeyra's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Aldeyra's market value can be influenced by many factors that don't directly affect Aldeyra's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Aldeyra's value and its price as these two are different measures arrived at by different means. Investors typically determine if Aldeyra is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Aldeyra's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.